Status | Study |
Recruiting |
Study Name: Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias Condition: Gestational Trophoblastic Neoplasias (GTN) Date: 2017-04-06 Interventions: Drug: Avelumab administration at 10mg/kg Avelumab administration at 10 mg/kg as a 1 hour IV infusion onc |
Recruiting |
Study Name: Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Condition: Adult Germ Cell Tumor Childhood Extracranial Germ Cell Tumor Date: 2017-02-14 Interventions: Other: Best Practice Undergo o |
Recruiting |
Study Name: The French National Reference Centre of GTD Condition: Neoplasm, Trophoblastic Gestational Trophoblastic Disease Date: 2016-08-02 |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Recruiting |
Study Name: Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes Condition: Pregnancy,Neoplastic Complications Date: 2016-04-13 |
Recruiting |
Study Name: Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) Condition: Gestational Trophoblastic Neoplasia Choriocarcinoma Placen Date: 2016-01-20 Interventions: Drug: TRC105 Subjects will beg |
Not yet recruiting |
Study Name: Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor Condition: Gestational Trophoblastic Neoplasms Date: 2015-12-13 Interventions: Drug: Etoposide etoposide 100m |
Recruiting |
Study Name: Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms Condition: Gestational Trophoblastic Neoplasms Date: 2015-08-08 Interventions: Procedure: Total abdominal hysterectomy and methotrexate |
Active, not recruiting |
Study Name: Single Patient Treatment Protocol of TRC105 Combined With Standard-dose Bevacizumab for a Single Patient With Metastatic And Refractory Choriocarcinoma Condition: Choriocarcinoma Date: 2015-03-05 Interventions: Biological: TRC105 weekly i.v. |
Recruiting |
Study Name: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Condition: Germ Cell Tumor Teratoma Choriocarcinoma Date: 2015-02-20 Interventions: Drug: paclitaxel IV |